ArticleCurrent pharmaceutical design2025

Targeting Anaplastic Lymphoma Kinase in Oncology: Identification and Computational Validation of Novel Inhibitors for Anaplastic Large Cell Lymphoma, Non-small Cell Lung Cancer, and Neuroblastoma.

Aftab Alam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.